2022-07-05-世界卫生组织-Immunization_Kuwait_2022_country_profile_16页_349kb

Kuwait - Immunization Coverage Summary

BCG Vaccine

• Coverage Trends (2010-2021):
  • 2010-2002: Consistently high coverage, around 98-99%, supported by reported data and administrative records ([R+, D+ surveys]).
  • 2019-2020: Interpolated estimates, confidence rating changed to No accepted empirical data.
  • Recent years: No nationally representative surveys within the past 5 years.
• Confidence Grade:
  • Most years: Good confidence ([R+, D+ surveys]), but with data interpolation in 2019 and 2020, confidence is rated as No accepted empirical data for those periods.

DTP1 (Diphtheria/Tetanus/Pertussis Vaccine)

• Coverage Trends (2010-2021):
  • 2010-2013: Stable at 97-99%, with some reliance on DTP3 estimates in 2016.
  • 2019-2020: Interpolated estimates, confidence rating changed to No accepted empirical data.
  • Recent years: Encouraging coverage, supported by reported data and administrative records.

DTP3 (Third Diphtheria/Tetanus/Pertussis Dose) & Pol3 (Third Polio Dose)

• Coverage Trends (2010-2021):
  • 2010-2011: Reports show coverage around 98-99%, with some increases and decreases over time.
  • 2012-2018: Consistently high coverage (91%-99%), though some estimates depended on administrative data and faced rating challenges.
  • 2019-2021: Interpolated estimates, with coverage rising steadily. Confidence rating demoted to No accepted empirical data.

MCV1 (Measles First Dose)

• Coverage Trends (2010-2021):
  • 2010-2018: Consistently high, averaging near 98-99%.
  • 2019-2020: Interpolated, lower confidence due to lack of empirical data.
  • Recent years: Encouraging coverage levels maintained.

MCV2 (Measles Second Dose)

• Coverage Trends (2010-2021):
  • Coverage remained stable at over 98% in recent years but faced confidence challenges with interpolation in multiple periods (2019-2020).

Hepat B Birth Dose

• Coverage Trends (2010-2021):
  • 2010-2017: Consistently around 98-99%, with stable confidence.
  • 2019-2020: Interpolated estimates, confidence rating lowered.

RCV1 (Rubella First Dose)

• Description: RCV estimates are derived from MCV1 estimates due to challenges in getting reliable rubella data.
• Coverage Trends:
  • Follows MCV1 trends closely; data quality depends on MCV reporting.

Summary Notes:

• Highest Confidence Periods: Immunization coverage estimates gained the highest confidence ([R+, D+, S+]) when the government provided direct data and independent denominator checks were performed.
• Lower Confidence Periods (e.g., 2019-2020): Interpolation and extrapolation led to reduced confidence.
• Recommendations: Countries like Kuwait are advised to maintain high-quality surveys to uphold confidence in coverage estimates.